The pathogenesis of dengue
- PMID: 21781999
- DOI: 10.1016/j.vaccine.2011.07.022
The pathogenesis of dengue
Abstract
Dengue is an important cause of childhood and adult morbidity in Asian and Latin American countries and its geographic footprint is growing. The clinical manifestations of dengue are the expression of a constellation of host and viral factors, some acquired, others intrinsic to the individual. The virulence of the virus plus the flavivirus infection history, age, gender and genotype of the host all appear to help shape the severity of infection. Similarly, the characteristics of the innate and acquired host immune response subsequent to infection are also likely determinants of outcome. This review summarises recent developments in the understanding of dengue pathogenesis and their relevance to dengue vaccine development.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Variation in virulence of dengue virus.Lancet. 1999 Oct 23;354(9188):1401-2. doi: 10.1016/S0140-6736(99)00236-6. Lancet. 1999. PMID: 10543660 No abstract available.
-
Induction of programmed cell death (apoptosis) by dengue virus in vitro and in vivo.Acta Cient Venez. 1998;49 Suppl 1:13-7. Acta Cient Venez. 1998. PMID: 10030049 Review.
-
Dengue virus therapeutic intervention strategies based on viral, vector and host factors involved in disease pathogenesis.Pharmacol Ther. 2013 Feb;137(2):266-82. doi: 10.1016/j.pharmthera.2012.10.007. Epub 2012 Oct 26. Pharmacol Ther. 2013. PMID: 23103333 Review.
-
Symptomatic Dengue in Children in 10 Asian and Latin American Countries.N Engl J Med. 2016 Mar 24;374(12):1155-66. doi: 10.1056/NEJMoa1503877. N Engl J Med. 2016. PMID: 27007959
-
Comments on the epidemiology, pathogenesis and control of dengue.Med Trop (Mars). 1999;59(4 Pt 2):495-8. Med Trop (Mars). 1999. PMID: 10901853
Cited by
-
CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.J Infect Dis. 2015 Nov 15;212(10):1618-28. doi: 10.1093/infdis/jiv258. Epub 2015 May 5. J Infect Dis. 2015. PMID: 25943203 Free PMC article.
-
Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection.J Biomed Sci. 2013 Jun 27;20(1):42. doi: 10.1186/1423-0127-20-42. J Biomed Sci. 2013. PMID: 23806052 Free PMC article. Review.
-
A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.Antimicrob Agents Chemother. 2020 Nov 17;64(12):e00654-20. doi: 10.1128/AAC.00654-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32958712 Free PMC article.
-
The Dual Role of the Antibody Response Against the Flavivirus Non-structural Protein 1 (NS1) in Protection and Immuno-Pathogenesis.Front Immunol. 2019 Jul 18;10:1651. doi: 10.3389/fimmu.2019.01651. eCollection 2019. Front Immunol. 2019. PMID: 31379848 Free PMC article. Review.
-
Antiviral Activities of Streptomyces KSF 103 Methanolic Extracts against Dengue Virus Type-2.Viruses. 2023 Aug 20;15(8):1773. doi: 10.3390/v15081773. Viruses. 2023. PMID: 37632115 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical